Combination of Immunotherapy and Antiangiogenic Therapy in Cancer—a Rational Approach
Author:
Funder
Eli Lilly and Company
Merck
Bayer Fund
AstraZeneca
Boehringer Ingelheim
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference26 articles.
1. Anti-angiogenic agents in combination with immune checkpoint inhibitors: a promising strategy for cancer treatment;Song;Front Immunol,2020
2. Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming;Tian;Nature,2017
3. Increased vessel perfusion predicts the efficacy of immune checkpoint blockade;Zheng;J Clin Invest,2018
4. Immunotherapy: combine and conquer - antiangiogenic immunotherapy;Killock;Nat Rev Clin Oncol,2017
5. Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges;Fukumura;Nat Rev Clin Oncol,2018
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Extended ICI treatment after first‐line chemoimmunotherapy could predict the clinical benefit of ramucirumab plus docetaxel in advanced non‐small lung cancer: Post hoc analysis from NEJ051 (REACTIVE study);Thoracic Cancer;2023-11-27
2. Treatment-related adverse events of immune checkpoint inhibitors combined with angiogenesis inhibitors in advanced lung cancer: A systematic review and meta-analysis;International Immunopharmacology;2023-10
3. Current status and future of anti-angiogenic drugs in lung cancer;Clinical and Experimental Medicine;2023-03-15
4. Atezolizumab Plus Bevacizumab as First-line Treatment for Patients With Metastatic Nonsquamous Non–Small Cell Lung Cancer With High Tumor Mutation Burden;JAMA Oncology;2023-03-01
5. Potential of VEGFR2 expression as a predictive marker of PD‑1 blockade in patients with advanced NSCLC;Oncology Reports;2022-10-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3